Page last updated: 2024-08-25

rosiglitazone and indirubin

rosiglitazone has been researched along with indirubin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Kobayashi, K; Konno, T; Murata, T; Sasaki, K	1

Other Studies

1 other study(ies) available for rosiglitazone and indirubin

Article	Year
Indirubin promotes adipocyte differentiation and reduces lipid accumulation in 3T3‑L1 cells via peroxisome proliferator‑activated receptor γ activation. Molecular medicine reports, 2020, Volume: 21, Issue:3 Topics: 3T3-L1 Cells; Adipocytes; Animals; Biomarkers; Cell Differentiation; Cell Proliferation; Glucose; Hypoglycemic Agents; Indoles; Insulin; Ligands; Lipid Metabolism; Mice; PPAR gamma; Protein Kinase Inhibitors; Rosiglitazone	2020

Article

Year

Indirubin promotes adipocyte differentiation and reduces lipid accumulation in 3T3‑L1 cells via peroxisome proliferator‑activated receptor γ activation.

Molecular medicine reports, 2020, Volume: 21, Issue:3

Topics: 3T3-L1 Cells; Adipocytes; Animals; Biomarkers; Cell Differentiation; Cell Proliferation; Glucose; Hypoglycemic Agents; Indoles; Insulin; Ligands; Lipid Metabolism; Mice; PPAR gamma; Protein Kinase Inhibitors; Rosiglitazone

2020